Boryung's self medication projects impressive.

Boryung announced on Jan. 1 this year that the OTC marketing division was renamed to the SM (self medication) division. Since then 2 month short term business performance of OTC products made a satisfactory achievement far beyond their target at 110%.

Astrix, an oral anti-platelet drug, showed the most prominent sales figure at 1.2 billion won just in Jan. and Feb., considering its annual ta...